ピロリ菌検査の世界市場 - 市場規模（セグメント別）、シェア、規制、償還、予測（～2033年）

当レポートでは、世界のピロリ菌検査市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みのピロリ菌検査と進化する競合情勢

• 主な業界動向の考察
• ピロリ菌検査市場のセグメント別の年間収益と市場の見通し（2015年～2033年）
• ユニット数、平均販売価格、市場金額に関する市場レベルのデータ

世界、地域、国レベルの市場固有の考察

• 世界の動向を地域別に分類した定性的な市場固有の情報と国別の考察
• ピロリ菌検査市場のSWOT分析
• ピロリ菌検査市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制情勢

対象企業

• Avanos Medical Inc
• Meridian Bioscience Inc
• DiaSorin SpA
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc
• bioMerieux SA
• Bio-Rad Laboratories Inc,Siemens AG
• Trinity Biotech Plc
• Merck KGaA
• Sekisui Chemical Ltd
• Sentinel CH. SpA
• Abbott Laboratories
• Quidelortho Corp
• TECHLAB Inc
• Agilent Technologies Inc
• Cardinal Health Inc
• Biocare Medical LLC
• Danaher Corp
• Werfen Life Group SAU
• MP Biomedicals LLC
• GI Supply Inc
• Serim Research Corporation
• Beckman Coulter Inc
• Polymedco Inc
• その他

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Helicobacter Pylori Tests market for the year 2020 and beyond. The Helicobacter Pylori Tests include Helicobacter pylori Breath Test, Helicobacter pylori Feces Test, Helicobacter pylori Serology EIA Test, Helicobacter pylori Rapid Urease Test, Helicobacter pylori Immunohistochemical Test and Helicobacter pylori(POC) Tests.

Peptic Ulcer Disease (PUD) is a break in the lining of the stomach, first part of small intestine and lower oesophagus occasionally. An ulcer in the stomach is also known as gastric ulcer, and an ulcer in the first part of the intestine is called a duodenal ulcer. Peptic ulcer is a chronic disease affecting up to 10% of the world's population.

H. pylori plays a predominant role in the etiology of GC and was characterized as a class I carcinogen by the World Health Organisation. The oncogenic effects of H. pylori can occur through a variety of mechanisms, including the indirect inflammatory effects of H. pylori on the gastric mucosa and the direct epigenetic effects of H. pylori on individual cells. Other indications include Dyspepsia and Gastric MALT Lymphoma.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Helicobacter Pylori Tests and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Helicobacter Pylori Tests market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Helicobacter Pylori Tests market.
• Competitive dynamics insights and trends provided for Helicobacter Pylori Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Avanos Medical Inc, Meridian Bioscience Inc, DiaSorin SpA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, bioMerieux SA, Bio-Rad Laboratories Inc,Siemens AG, Trinity Biotech Plc, Merck KGaA, Sekisui Chemical Ltd, Sentinel CH. SpA, Abbott Laboratories, Quidelortho Corp, TECHLAB Inc, Agilent Technologies Inc, Cardinal Health Inc, Biocare Medical LLC, Danaher Corp, Werfen Life Group SAU, MP Biomedicals LLC, GI Supply Inc, Serim Research Corporation, Beckman Coulter Inc, Polymedco Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Helicobacter Pylori Tests market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Helicobacter Pylori Tests market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Helicobacter Pylori Tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Helicobacter Pylori Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Helicobacter Pylori Tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable